NCT06691659 Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation
| NCT ID | NCT06691659 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Radiation Protection |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-11-19 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-11-19 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardiothoracic, musculoskeletal, and neuroimaging.
Eligibility Criteria
Inclusion Criteria: * Age 18 to 89. * Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures. * Not pregnant (based on attestation) Exclusion Criteria: * Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant before CT imaging. * Participants with a known contrast allergy. * Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.
Contact & Investigator
Peter B Noel, PhD
PRINCIPAL INVESTIGATOR
UPENN Radiology
Frequently Asked Questions
Who can join the NCT06691659 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Radiation Protection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06691659 currently recruiting?
Yes, NCT06691659 is actively recruiting participants. Contact the research team at erin.schubert@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06691659 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06691659 clinical trial?
NCT06691659 is sponsored by University of Pennsylvania. The principal investigator is Peter B Noel, PhD at UPENN Radiology. The trial plans to enroll 250 participants.